Category

CEA/CUA

Home > Project Types > CEA/CUA (Page 4)

Bastos-Oreiro M, de las Heras A, Presa M, Casado MA, Pardo C, Martín-Escudero V, Sureda A

 

 

Cost-Effectiveness Analysis of Axicabtagene Ciloleucel vs Tisagenlecleucel for the Management of Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Spain
Cancers 2022; 14(3), 538

Estrada V, Górgolas M, Peña JA, Tortajada E, Castro A, Presa M, Oyagüez I

 

 

Epidemiologic and economic analysis of rapid antiretroviral therapy initiation with bictegravir/emtricitabine/tenofovir alafenamide in Spain
PharmacoEconomics – Open
https://doi.org/10.1007/s41669-022-00322-w

García-Herola A, Domínguez-Hernández R, Casado MA

 

 

Clinical and economic impact of an alert system in primary care for the detection of patients with chronic hepatitis C
PLoS One. 2021; 16(12)

Fernández Sanchis D, Cuenca Zaldívar JN, Calvo S, Herrero P, Gómez Barrera M

 

 

Cost-effectiveness of upper extremity dry needling in the rehabilitation of patients with stroke
Acupuncture in medicine. DOI: 10.1177/09645284211055750

Forns X, Colom J, García-Retortillo M, Quer JC, Lens S, Martró E, Domínguez-Hernández R, Casado MA, Buti M

 

 

Point-of-care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C elimination
J Viral Hepat. 2021;00:1–4

MÁS INFORMACIÓN

Moltó J, González J, Navarro C, Castro A, Presa M, Oyagüez I

 

 

Cribado dirigido del Virus de la Inmunodeficiencia Humana en los servicios de urgencias en España: análisis de las consecuencias epidemiológicas y económicas
Emergencias 2022;34:21-28

Bastos-Oreiro M, de las Heras A, Presa M, Casado MA, Pardo C, Martín-Escudero V, Sureda A

 

 

Axicabtagene ciloleucel and tisagenlecleucel for the treatment of relapsed/refractory diffuse large B-cell lymphoma in Spain: a cost-effectiveness analysis
24th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Virtual. 30 nov-3 dic 2021

POSTER

Vargas-Accarino E, Martínez-Campreciós J, Domínguez-Hernández R, Rando-Segura A, Riveiro-Barciela M, Rodríguez-Frías F, Barreira A, Palom A, Casado MA, Esteban R, Buti M

 

Impact of COVID-19 pandemic in the ReLink-C strategy to search and retrieve lost-to follow-up HCV patients
The Liver Meeting Digital Experience – AASLD. Digital. 12-15 nov 2021

Bastos-Oreiro M, de las Heras A, Presa M, Casado MA, Pardo C, Martín-Escudero V, Sureda A

 

 

Eficiencia de axicabtagén ciloleucel versus tisagenlecleucel en el tratamiento del linfoma B difuso de células grandes en recaída o refractario en España
LXIII Congreso Nacional de la SEHH y XXXVII Congreso Nacional de la SETH. Pamplona. 14-16 oct 2021